Malignant T-cell-amplified sequence 2 (MCTS2)

Malignant T-cell-amplified sequence 2 (MCTS2) is a gene annotated in both human and mouse genomes. In humans (MCTS2_HUMAN), UniProt and InterPro list the protein entry but give minimal annotation or supporting evidence for mature protein expression. In mouse, Mcts2 is predicted to have RNA binding activity and to be involved in the formation of the translation preinitiation complex, but there is little experimental validation in either species. The designation as a "pseudogene" and scarcity of curated functional information strongly suggest that, in humans at least, MCTS2 is not a well-characterized protein-coding gene and not a recognized therapeutic target in drug discovery or clinical practice. There are no reported drugs, mechanisms of action, or recognized biomarker utility connected to this locus, and the biological and disease roles are not established in the literature. Accordingly: - The gene is commonly annotated as a pseudogene or minimally characterized gene. - There is no evidence it functions as a druggable receptor, enzyme, transporter, or transcription factor. - It is not considered a therapeutic target, and there is likely incorrectness in proposing it as such for standard drug discovery purposes. Additional notes: This name is easily confused with MCTS1 (Malignant T-cell-amplified sequence 1), which is a well-characterized protein involved in cell cycle regulation and is sometimes discussed in cancer research contexts. Be careful not to conflate MCTS2 and MCTS1, as only the latter has a demonstrated protein function and disease association. Summary: - MCTS2 (Malignant T-cell-amplified sequence 2) should be classified as a pseudogene or poorly characterized gene, not a therapeutic target or receptor. - There are no known interacting drugs, mechanisms, or biomarker uses. - Considered an incorrect target designation for most drug development or molecular pharmacology purposes.

Other names

MCTS2psiMCT-1MCTS2PPSIMCT-1malignant T-cell-amplified sequence 2MCTS family member 2, pseudogenemalignant T cell amplified sequence 1 pseudogenemalignant T cell amplified sequence 2, pseudogene